Title |
Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers.
|
---|---|
Published in |
Genome Medicine, February 2014
|
DOI | 10.1186/gm535 |
Pubmed ID | |
Authors |
Ahn JW, Kim HS, Yoon JK, Jang H, Han SM, Eun S, Shim HS, Kim HJ, Kim DJ, Lee JG, Lee CY, Bae MK, Chung KY, Jung JY, Kim EY, Kim SK, Chang J, Kim HR, Kim JH, Lee MG, Cho BC, Lee JH, Bang D, Jin Ahn, Han Kim, Jung-Ki Yoon, Hoon Jang, Soo Han, Sungho Eun, Hyo Shim, Hyun-Jung Kim, Dae Kim, Jin Lee, Chang Lee, Mi Bae, Kyung Chung, Ji Jung, Eun Kim, Se Kim, Joon Chang, Hye Kim, Joo Kim, Min Lee, Byoung Cho, Ji Lee, Duhee Bang |
Abstract |
Lung adenocarcinoma is a highly heterogeneous disease with various etiologies, prognoses, and responses to therapy. Although genome-scale characterization of lung adenocarcinoma has been performed, a comprehensive somatic mutation analysis of EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers has not been conducted. |
Twitter Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Ireland | 1 | 20% |
United States | 1 | 20% |
United Kingdom | 1 | 20% |
Romania | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 40% |
Scientists | 2 | 40% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Korea, Republic of | 2 | 4% |
United States | 1 | 2% |
Unknown | 52 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 12 | 22% |
Student > Ph. D. Student | 11 | 20% |
Professor | 5 | 9% |
Professor > Associate Professor | 5 | 9% |
Student > Doctoral Student | 4 | 7% |
Other | 10 | 18% |
Unknown | 8 | 15% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 15 | 27% |
Biochemistry, Genetics and Molecular Biology | 13 | 24% |
Medicine and Dentistry | 9 | 16% |
Chemistry | 2 | 4% |
Business, Management and Accounting | 1 | 2% |
Other | 2 | 4% |
Unknown | 13 | 24% |